Ustekinumab for psoriatic arthritis

被引：12

作者：

Cuchacovich, Raquel S. ^{[1
]}

Espinoza, Luis R. ^{[1
]}

机构：

[1] Louisiana State Univ, Hlth Sci Ctr, Rheumatol Sect, Dept Med, New Orleans, LA 70112 USA

来源：

LANCET | 2009年 / 373卷 / 9664期

关键词：

THERAPY; EXPRESSION; EFFICACY; SAFETY;

D O I：

10.1016/S0140-6736(09)60141-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：605 / 606

页数：2

共 12 条

[1]

Candia L, 2007, J RHEUMATOL, V34, P374

[2] Biologic Therapy(TNF-α Antagonists)-Induced Psoriasis A Cytokine Imbalance Between TNF-α and IFN-α? [J].

Cuchacovich, Raquel ;

Espinoza, Carmen G. ;

Virk, Zia ;

Espinoza, Luis R. .

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2008, 14 (06) :353-356

[3] Pathophysiology of psoriasis: Recent advances on IL-23 and TH17 cytokines [J].

Fitch E. ;

Harper E. ;

Skorcheva I. ;

Kurtz S.E. ;

Blauvelt A. .

Current Rheumatology Reports, 2007, 9 (6) :461-467

[4]

Genovese MC, 2007, J RHEUMATOL, V34, P1040

[5]

GOTTLIEB A, 2009, LANCET 0212, DOI DOI 10.1016/S0140-6736(09)60140-9

[6]

Helliwell PS, 2008, J RHEUMATOL, V35, P472

[7] Pathogenesis and therapy of psoriasis [J].

Lowes, Michelle A. ;

Bowcock, Anne M. ;

Krueger, James G. .

NATURE, 2007, 445 (7130) :866-873

[8] Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2) [J].

Papp, Kim A. ;

Langley, Richard G. ;

Lebwohl, Mark ;

Krueger, Gerald G. ;

Szapary, Philippe ;

Yeilding, Newman ;

Guzzo, Cynthia ;

Hsu, Ming-Chun ;

Wang, Yuhua ;

Li, Shu ;

Dooley, Lisa T. ;

Reich, Kristian .

LANCET, 2008, 371 (9625) :1675-1684

[9] In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: Enhanced expression in psoriatic skin [J].

Piskin, G ;

Sylva-Steenland, RMR ;

Bos, JD ;

Teunissen, MBM .

JOURNAL OF IMMUNOLOGY, 2006, 176 (03) :1908-1915

[10]

Saketkoo LA, 2008, J RHEUMATOL, V35, P369

← 1 2 →